Tissue Regenix Group PLC
LSE:TRX

Watchlist Manager
Tissue Regenix Group PLC Logo
Tissue Regenix Group PLC
LSE:TRX
Watchlist
Price: 0.0725 GBX
Market Cap: 5.2m GBX

Gross Margin
Tissue Regenix Group PLC

41.4%
Current
47%
Average
63.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
41.4%
=
Gross Profit
10.8m
/
Revenue
26m

Gross Margin Across Competitors

No Stocks Found

Tissue Regenix Group PLC
Glance View

Market Cap
5.2m GBX
Industry
Biotechnology

Tissue Regenix Group Plc is a medical technology company, which develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine. The company is headquartered in Leeds, West Yorkshire and currently employs 79 full-time employees. The company went IPO on 2006-12-21. The firm is focused on the development of regenerative products using its two platform technologies: decellularization (dCELL), which is used to produce allograft (DermaPure) and xenograft (OrthoPure XT) soft tissue products to promote healing and regeneration, and BioRinse, which is a natural bone filler solution verified to be osteoinductive to stimulate and regenerate native bone growth. The firm is engaged in transforming the treatment of patients in surgical applications, including BioSurgery, Orthopaedics (sports medicine/spine), Dental, General, Plastic Surgery, Urology/Gynaecology, Ophthalmology and Cardiac.

TRX Intrinsic Value
0.7832 GBX
Undervaluation 91%
Intrinsic Value
Price
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
41.4%
=
Gross Profit
10.8m
/
Revenue
26m
What is the Gross Margin of Tissue Regenix Group PLC?

Based on Tissue Regenix Group PLC's most recent financial statements, the company has Gross Margin of 41.4%.

Back to Top